Trials / Completed
CompletedNCT00037661
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | INS365 Ophthalmic Solution |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2003-03-01
- Completion
- 2003-03-01
- First posted
- 2002-05-20
- Last updated
- 2015-10-02
Source: ClinicalTrials.gov record NCT00037661. Inclusion in this directory is not an endorsement.